PUOTI MASSIMO

Renisi, G., Comelli, A., Scudeller, L., Mazzone, A., Macaluso, G., Zanforlini, M., et al. (2026). Antimicrobial Stewardship (AMS) program in Lombardy region: analysis of effectiveness and costs. In Abstract Book 2026 36th Congress of the European Society of Clinical Microbiology and Infectious Diseases (pp.1-4). Detail

Benedittis, S., Tavelli, A., Gagliardini, R., Bini, T., Guastavigna, M., Mazzotta, V., et al. (2026). Peer-supported digital collection of patient-reported outcomes in HIV care: Promise, practical barriers and lessons from a pilot study within the ICONA cohort. HIV MEDICINE, 27(5), 815-818 [10.1111/hiv.70214]. Detail

Aghemo, A., Ciancio, A., Claar, E., Coppola, N., Mangia, A., Riglietta, M., et al. (2026). Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir–Velpatasvir. VIRUSES, 18(8) [10.3390/v18080854]. Detail

Rossotti, R., Bana, N., Cavazza, G., Puoti, M. (2026). Absence of Pharmacodynamic Interference Following Concomitant Administration of Long-Acting Cabotegravir/Rilpivirine and Intramuscular Antibiotics for Sexually Transmitted Infections in People with HIV. CURRENT HIV RESEARCH [10.2174/011570162X408164251203102620]. Detail

Chalouni, M., Torgersen, J., Rentsch, C., Van Santen, D., Jarrin, I., Klein, M., et al. (2026). Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIV. AIDS, 40(8), 1073-1081 [10.1097/QAD.0000000000004499]. Detail